JPRN-UMIN000008084尚未招募未知
The clinical study of beta 3-agonist (Betanis) for lower urinary tract symptoms mainly for overactive bladder - The clinical study of beta 3-agonist for lower urinary tract symptoms
Dept. of Urology, Kyoto University Hospital0 个研究点目标入组 100 人开始时间: 2012年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) those who have critical infectious disease or have uncontrollable complications (2) those who have active urothelial cancer or prostate cancer (3) those who have critical heart disease (4) those who have the episode of urinary retention (5) those who are considered as inappropriate for this study by the responsible doctor
研究者
相似试验
尚未招募
2 期
A randomized controlled trial for beta agonist on ulolithiasis patients associated with overactive bladder.urolithiasisJPRN-UMIN000010553Department of Urology, Isehara Kyodo Hospital100
Unknown
1 期
Beta 3 Agonists in Treatment of Non-neurogenic Voiding Dysfunction in ChildrenVoiding DisordersOveractive BladderNCT05240456Mansoura University70
已完成
不适用
Clinical efficacy and safety of a beta3-adrenoceptor agonist and an antimuscarinic agent in female patients with overactive overactive bladder: a randomized crossover studyOveractive bladderJPRN-UMIN000010060ara Medical University100
进行中（未招募）
1 期
Evaluation of Beta Blockers for the Treatment of Asthma. A randomised controlled trial of propranolol.MedDRA version: 12.1Level: LLTClassification code 10003553Term: AsthmaasthmaEUCTR2009-017356-28-GBniversity of Dundee15
已完成
2 期
Effect of Interferon beta-1-b on COVID-19 patientsCovid 19.Covid 19 , Virus IdentifiedU07.1IRCT20201001048894N1Bandare-abbas University of Medical Sciences90